Potassium Chloride 500 mg/5 mL Liquid
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Chlorure de potassium Source : Chlorure de potassium Potency : 52.45 mg/ml Potassium | 100 mg/ml | Not calculated |
Non-medicinal ingredients
Aspartame, Glycérol, Sorbate de potassium, Eau, Benzoate de sodium, Sorbitol, Saveur, D-Fructose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 7.5 millilitre ; maximum: 15 millilitre | minimum: 2 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
For the treatment of metabolic alkalosis. Treatment or prevention of hypokalemia (potassium depletion) which does not result from dietary deficiency. Used for the treatment of digitalis toxicity and as potassium replacement therapy or as an eclectrolyte replenisher.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Where impaired renal function exists, the use of potassium supplements must be monitored closely. The use of potassium supplements with potassium spanning diuretics (spironolactone, triamterene, amilorlde) may lead to hyperkalemia. Not to be used following vigorous exercise or acute dehydration (unless administered with an appropriate balance of other mineral salts, e.g. sodium). Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Discontinue use and consult a health care practitioner immediately if you experience numbness of the extremities, muscle weakness, paralysis, cardiac arrhythmias, low blood pressure, or confusion. Do not use if you have a heart condition adrenal insufficiency or uncontrolled diabetes mellitus, or if you are taking any prescription medications especially those which increase serum containing supplements or with potassium-containing salt-substitutes. May cause nausea, vomiting, diarrhea, abdominal cramps, discontinue use and consult a health care practitioner if these symptoms are severe. To be taken only on the advice of a physician. Consult a health care practitioner prior to use if you have a kidney disorder.
Product record
- Licence holder
- BIOVANTEK
- NPN or DIN-HM
- 80071796
- Status
- Inactive licence
- Licence date
- 8 August 2016
- Revision date
- 18 May 2022
- Form
- Liquide oral, solution
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80071796
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Potassium Chloride 500 mg/5 mL Liquid”, https://compoatlas.com/en/supplements/canada/80071796-potassium-chloride-500-mg-5-ml-liquid, updated 18 May 2022.